Terms: = Bone cancer AND ER, estrogen receptor AND Prognosis
163 results:
1. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract] [Full Text] [Related]
2. The Effects of Fucoidan Derived from
Gupta D; Martinez DC; Puertas-Mejía MA; Hearnden VL; Reilly GC
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396762
[TBL] [Abstract] [Full Text] [Related]
3. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
[TBL] [Abstract] [Full Text] [Related]
4. Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population-based study.
Zhou X; Liu M; Zheng Z; Cao X; Lin Y; Xu Y; Li Y; Wang HC; Sun Q
Cancer; 2024 Apr; 130(S8):1464-1475. PubMed ID: 38198445
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
6. Long-Term Follow-Up of Tamoxifen Treatment and the Use of Imaging in Psammocarcinoma: A Case Report, Review of the Literature and Discussion of Diagnostic and Therapeutic Challenges.
Gideonsson I; Israelsson P; Strandberg SN; Ottander U
Curr Oncol; 2023 Nov; 30(12):10260-10271. PubMed ID: 38132381
[TBL] [Abstract] [Full Text] [Related]
7. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast cancer with Focus on Triple-negative Breast cancer.
Naeimzadeh Y; Heidari Z; Razban V; Khajeh S
Curr Mol Pharmacol; 2024; 17(1):e18761429263841. PubMed ID: 37916633
[TBL] [Abstract] [Full Text] [Related]
8. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning.
Zhong X; Lin Y; Zhang W; Bi Q
Sci Rep; 2023 Oct; 13(1):18301. PubMed ID: 37880320
[TBL] [Abstract] [Full Text] [Related]
9. Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Gerratana L; Davis AA; Velimirovic M; Clifton K; Hensing WL; Shah AN; Dai CS; Reduzzi C; D'Amico P; Wehbe F; Medford A; Wander SA; Gradishar WJ; Behdad A; Puglisi F; Ma CX; Bardia A; Cristofanilli M
Breast Cancer Res; 2023 Oct; 25(1):112. PubMed ID: 37784176
[TBL] [Abstract] [Full Text] [Related]
10. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract] [Full Text] [Related]
11. Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial.
Volmer LL; Dannehl D; Engler T; Hahn M; Walter CB; Wallwiener M; Brucker SY; Taran FA; Hartkopf AD
Breast Cancer Res Treat; 2023 Nov; 202(1):67-72. PubMed ID: 37556015
[TBL] [Abstract] [Full Text] [Related]
12. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract] [Full Text] [Related]
13. An Immunohistochemical Study of Breast cancer Brain Metastases: The Role of CD44 and AKT in the prognosis.
Martins Gama J; Caetano Oliveira R; Teixeira P; Silva F; Abrantes C; Figueiredo P; Simões S; Rebelo O; Cipriano MA
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):318-323. PubMed ID: 37093706
[TBL] [Abstract] [Full Text] [Related]
14. Genistein and coumestrol reduce MCF-7 breast cancer cell viability and inhibit markers of preferential metastasis, bone matrix attachment and tumor-induced osteoclastogenesis.
Al-Thamiree Mezban S; Fox SW
Arch Biochem Biophys; 2023 May; 740():109583. PubMed ID: 36967033
[TBL] [Abstract] [Full Text] [Related]
15. RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.
Ciscar M; Trinidad EM; Perez-Chacon G; Alsaleem M; Jimenez M; Jimenez-Santos MJ; Perez-Montoyo H; Sanz-Moreno A; Vethencourt A; Toss M; Petit A; Soler-Monso MT; Lopez V; Gomez-Miragaya J; Gomez-Aleza C; Dobrolecki LE; Lewis MT; Bruna A; Mouron S; Quintela-Fandino M; Al-Shahrour F; Martinez-Aranda A; Sierra A; Green AR; Rakha E; Gonzalez-Suarez E
EMBO Mol Med; 2023 Apr; 15(4):e16715. PubMed ID: 36880458
[TBL] [Abstract] [Full Text] [Related]
16. Oophorectomy in Premenopausal Patients with estrogen receptor-Positive Breast cancer: New Insights into Long-Term Effects.
Khan F; Rojas K; Schlumbrecht M; Jeudin P
Curr Oncol; 2023 Feb; 30(2):1794-1804. PubMed ID: 36826100
[TBL] [Abstract] [Full Text] [Related]
17. TOR1B: a predictor of bone metastasis in breast cancer patients.
Nguyen MN; Akter S; Akhter H; Ansary S; Han S; Shin Y; Ha J; Kang I; Kim SS; Choi TG
Sci Rep; 2023 Jan; 13(1):1495. PubMed ID: 36707670
[TBL] [Abstract] [Full Text] [Related]
18. Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma.
Zhu P; Li T; Li Q; Gu Y; Shu Y; Hu K; Chen L; Peng X; Peng J; Hao L
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551309
[TBL] [Abstract] [Full Text] [Related]
19. Risk stratification system and visualized dynamic nomogram constructed for predicting diagnosis and prognosis in rare male breast cancer patients with bone metastases.
Gao B; Ou XL; Li MF; Wang MD; Huang F
Front Endocrinol (Lausanne); 2022; 13():1013338. PubMed ID: 36440188
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and prognostic significance of receptor discordance between primary breast cancer and paired bone metastases.
Lin M; Jin Y; Lv H; Hu X; Zhang J
Int J Cancer; 2023 Apr; 152(7):1476-1489. PubMed ID: 36408915
[TBL] [Abstract] [Full Text] [Related]
[Next]
